Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Clover Health Investments, Corp.NASDAQ: CLOV

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $590.17M rose 56.1% year over year, behind the +64.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at +16.5% a year.

Context

  • Cost of revenue amounted to 81.5% of revenue in FY2025, up 8.1 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +56.1% toward the trailing-twelve-month pace of +64.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$590.17M+0.1% QoQ
Last fiscal yearDec 2025
$1.57B+55.9% YoY
LTMJun 2026
$2.02B+64.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+56.1%——
1 year+55.9%——
3-year CAGR+16.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
1.57B USD
Year-over-year change
+55.9%
4-year CAGR
+0.3%

Cost of Revenue vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 cost of revenue of $2.02B is the lowest of the 7 companies compared; the peer median is $148.31B.
  • Its year-over-year change of +64.7% is the highest of 7, against a peer median of +14.8%.
  • Cost of revenue amounts to 81.4% of revenue for CLOV, versus a peer median of 86.4%.
CLOV Competitors Peer median
Cost of Revenue for CLOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CVSCVS Health CorporationLTM Jun 2026$356.34B +6.9%+9.0%85.8%
CICigna CorporationLTM Sep 2026$256.93B +6.5%+16.6%89.7%
CNCCentene CorporationLTM Jun 2026$162.49B +0.1%+10.2%83.9%
HUMHumana Inc.LTM Sep 2026$134.12B +24.8%+13.5%87.0%
OSCROscar Health, Inc.LTM Jun 2026$8.44B +22.7%—55.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$3.73B +40.5%+40.4%87.6%
CLOVClover Health Investments, Corp.LTM Jun 2026$2.02B +64.7%+16.5%81.4%
Peer median (excluding CLOV) $148.31B+14.8%+13.5%86.4%

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.